Is a common food fungus worsening the AIDS epidemic?

July 23, 2013 by Greg Williams

A type of fungus coating much of the stored corn, wheat, rice and nuts in developing countries may be quietly worsening the AIDS epidemic, according to a paper published in the World Mycotoxin Journal.

Kept in sacks piled in barns and warehouses, food stores in countries near the equator are contaminated by Aspergillus flavus and A. parasiticus, fungi that produce a toxic substance called . About 4.5 billion people worldwide are exposed to aflatoxin at unsafe levels, and chronic exposure has been linked to and related cancers; but its role in the spread of infectious disease could make it even more deadly.

"Our work suggests study that aflatoxin exposure may be taking an even greater toll in areas where millions are infected with HIV, including Africa and Asia, the latter with a fast-growing HIV population and rice storage areas contaminated by fungi," said Pauline, Jolly, Ph.D., professor in the Department of Epidemiology within the School of Public Health at the University of Alabama at Birmingham (UAB). Strict regulation and monitoring minimize exposure in the United States.

Jolly and her colleagues recruited 314 HIV-positive people who were not yet on antiretroviral therapy for the study in Kumasi, Ghana. They divided patients into four groups based on their level of aflatoxin exposure and found that those in the highest exposure group were 2.6 times more likely to have a high HIV viral load than those in the lowest exposure group. Higher viral load translates into higher rates of HIV transmission and the potential for earlier progression to the opportunistic infections of AIDS.

"Previous studies by our team had looked at the possible interaction of aflatoxin and HIV on , and this study examined twice as many patients as previous studies," said Jolly, the study's corresponding author. "It also was structured to eliminate factors such as opportunistic infections and antiviral in clarifying the relationship between aflatoxin exposure and HIV for the first time."

Leading theories suggest that the fungal toxin may suppress the immune system by reducing the production of certain immune cells or the proteins that activate them. The toxin also may increase the expression of genes that result in more copies of the virus, but more study is needed to confirm the mechanisms.

Explore further: Researchers find immune cells may play previously unrecognized role in inflammation in HIV/AIDS

Related Stories

Researchers find immune cells may play previously unrecognized role in inflammation in HIV/AIDS

May 29, 2013
(Medical Xpress)—Depleted numbers of a specific type of white blood cell in the immune systems of people infected with HIV/AIDS appear to be associated with increased levels of unchecked and often damaging inflammation ...

Highly active antiretroviral therapies may be cardioprotective in HIV-infected children, teens

April 22, 2013
Long-term use of highly active antiretroviral therapies (HAART) does not appear to be associated with impaired heart function in children and adolescents in a study that sought to determine the cardiac effects of prolonged ...

HIV no barrier to getting liver transplant, study finds

May 17, 2013
(HealthDay)—Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.

When AIDS viruses are transmitted despite treatment

June 24, 2013
While antiretroviral drugs offer an efficient means of preventing the replication of HIV in the blood, shedding of HIV may occur in semen, so that other persons can become infected during unprotected sexual intercourse. This ...

Preventing HIV infection with anti-HIV drugs in people at risk is cost-effective

March 12, 2013
An HIV prevention strategy in which people at risk of becoming exposed to HIV take antiretroviral drugs to reduce their chance of becoming infected (often referred to as pre-exposure prophylaxis or PrEP), may be a cost-effective ...

Harnessing immune cells' adaptability to design an effective HIV vaccine

March 21, 2013
In infected individuals, HIV mutates rapidly to escape recognition by immune cells. This process of continuous evolution is the main obstacle to natural immunity and the development of an effective vaccine. A new study published ...

Recommended for you

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

Heart toxin reveals new insights into HIV-1 integration in T cell genome

July 20, 2017
Human immunodeficiency virus (HIV)-1 may have evolved to integrate its genetic material into certain immune-cell-activating genes in humans, according to new research published in PLOS Pathogens.

Scientists capture first high-resolution image of key HIV protein transitional state

July 13, 2017
A new, three-dimensional snapshot of HIV demonstrates the radical structural transformations that enable the virus to recognize and infect host cells, according to a new study led by scientists at The Scripps Research Institute ...

Barrier to autoimmune disease may open door to HIV, study suggests

July 11, 2017
Researchers from the University of Colorado School of Medicine have discovered that a process that protects the body from autoimmune disease also prevents the immune system from generating antibodies that can neutralize the ...

Team tests best delivery mode for potential HIV vaccine

June 20, 2017
For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

Mathematical modeling uncovers mysteries of HIV infection in the brain

June 19, 2017
After uncovering the progression of HIV infection in the brain thanks to a new mathematical model developed by a UAlberta research team, clinicians and researchers are developing a nasal spray to administer drugs more effectively.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.